Monoclonal antibody orange red background 3d rendering
Biotech

Allogene reports patient death tied to mAb in CAR-T pivotal trial

Given the patient death, the company is dropping the monoclonal antibody called ALLO-647 completely, CEO David Chang told Fierce.
Gabrielle Masson Aug 1, 2025 8:30am
Rethinking Clinical Trial Data in the Era of Decentralization

Rethinking Clinical Trial Data in the Era of Decentralization

Jul 28, 2025 8:00am
Mice playing around tubes in a rack in the lab

Big Pharma-backed program seeks future beyond animal testing

Aug 1, 2025 5:00pm
IV drip healthcare and medicine with doctor and patient in hospital

Baxter cuts financial forecasts, pauses infusion pump shipments

Aug 1, 2025 12:00pm
Grand Cayman on the Cayman Islands

Lepu supplies 2 T-cell engagers to NewCo in $857M deal

Aug 1, 2025 11:11am
Cartoon of businessmen standing around a broken target

Spine BioPharma misses primary endpoint in back pain phase 3

Aug 1, 2025 10:24am
More News

Novo Nordisk nominates CEO successor—Chutes & Ladders

Aug 1, 2025 8:30am

Sanofi pens $395M China pact for Arrowhead metabolic med

Aug 1, 2025 7:21am

4DMT climbs as gene therapy patients keep jettisoning jabs

Aug 1, 2025 5:35am

Fierce Biotech Layoff Tracker 2025: Moderna, Merck & more

Jul 31, 2025 2:45pm